journal article·2022-06Open access

Genetic Deficiency of MicroRNA‐15a/16‐1 Confers Resistance to Neuropathological Damage and Cognitive Dysfunction in Experimental Vascular Cognitive Impairment and Dementia

Chao Zhou, Ping Sun, Yang Xu, Yuang Chen, Yixian Huang, Milton H. Hamblin, Lesley Foley, T. Kevin Hitchens, Song Li, Ke‐Jie Yin

Advanced Science· Volume 9· Issue 17

Abstract

Abstract Chronic cerebral hypoperfusion‐derived brain damage contributes to the progression of vascular cognitive impairment and dementia (VCID). Cumulative evidence has shown that microRNAs (miRs) are emerging as novel therapeutic targets for CNS disorders. In this study, it is sought to determine the regulatory role of miR‐15a/16‐1 in VCID. It is found that miR‐15a/16‐1 knockout (KO) mice exhibit less cognitive and sensorimotor deficits following VCID. Genetic deficiency of miR‐15a/16‐1 in VCID mice also mitigate myelin degeneration, axonal injury, and neuronal loss. Mechanistically, miR‐15a/16‐1 binds to the 3’‐UTR of AKT3 and IL‐10RA. Genetic deletion of miR‐15a/16‐1 increases AKT3 and IL‐10RA expression in VCID brains, and intranasal delivery of AKT3 and IL‐10RA siRNA‐loaded nanoparticles partially reduce brain protection and cognitive recovery in miR‐15a/16‐1 KO mice after VCID. In conclusion, the miR‐15a/16‐1‐IL/10RA/AKT3 axis plays a critical role in regulating vascular brain damage and cognitive decline after VCID. Targeting miR‐15a/16‐1 is a novel therapeutic approach for the treatment of VCID.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neurological Disease Mechanisms and Treatments · MicroRNA in disease regulation · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pittsburgh Institute of Brain Disorders & Recovery Department of Neurology University of Pittsburgh School of Medicine Pittsburgh PA 15213 USA

Center for Pharmacogenetics University of Pittsburgh School of Pharmacy Pittsburgh PA 15213 USA

Tulane University Health Sciences Center Tulane University New Orleans LA 70112 USA

Animal Imaging Center Department of Neurobiology University of Pittsburgh School of Medicine Pittsburgh PA 15203 USA

Geriatric Research Education and Clinical Center Veterans Affairs Pittsburgh Healthcare System Pittsburgh PA 15240 USA

Funding

National Institutes of Health

References (79)

Show source-provided references
1. 10.1177/089198871665498710.1177/0891988716654987 ↗
2. 10.1016/S0140-6736(15)00463-810.1016/S0140-6736(15)00463-8 ↗
3. 10.1016/S1474-4422(03)00305-310.1016/S1474-4422(03)00305-3 ↗
4. 10.1161/01.STR.0000020094.08790.4910.1161/01.STR.0000020094.08790.49 ↗
5. 10.1016/S1474-4422(07)70195-310.1016/S1474-4422(07)70195-3 ↗
6. 10.1016/j.bbadis.2016.01.01510.1016/j.bbadis.2016.01.015 ↗
7. 10.1111/cns.1347210.1111/cns.13472 ↗
8. 10.1111/jnc.1427110.1111/jnc.14271 ↗
9. 10.1042/CS2016072710.1042/CS20160727 ↗
10. 10.1177/0271678X1876408310.1177/0271678X18764083 ↗
11. 10.1080/01616412.2017.135542310.1080/01616412.2017.1355423 ↗
12. 10.1523/JNEUROSCI.3970-14.201510.1523/JNEUROSCI.3970-14.2015 ↗
13. 10.1177/0271678X1774367010.1177/0271678X17743670 ↗
14. 10.1038/s41380-020-00971-510.1038/s41380-020-00971-5 ↗
15. 10.1016/0006-8993(94)01436-L10.1016/0006-8993(94)01436-L ↗
16. 10.1016/j.neuron.2013.10.00810.1016/j.neuron.2013.10.008 ↗
17. 10.1093/ageing/afx09010.1093/ageing/afx090 ↗
18. 10.1001/jama.292.23.290110.1001/jama.292.23.2901 ↗
19. 10.18632/aging.10048610.18632/aging.100486 ↗
20. 10.1038/cddis.2017.24310.1038/cddis.2017.243 ↗
21. 10.1159/00049284410.1159/000492844 ↗
22. 10.1159/00047891910.1159/000478919 ↗
23. 10.2174/156720261466617110111530810.2174/1567202614666171101115308 ↗
24. 10.1016/j.ejphar.2017.10.02710.1016/j.ejphar.2017.10.027 ↗
25. 10.3389/fnmol.2018.0038810.3389/fnmol.2018.00388 ↗
26. 10.3389/fncel.2018.0015410.3389/fncel.2018.00154 ↗
27. 10.1177/0271678X1880059310.1177/0271678X18800593 ↗
28. 10.1523/JNEUROSCI.1997-12.201310.1523/JNEUROSCI.1997-12.2013 ↗
29. 10.1007/s12035-016-0268-610.1007/s12035-016-0268-6 ↗
30. 10.1161/STROKEAHA.117.01728410.1161/STROKEAHA.117.017284 ↗
31. 10.1161/CIRCRESAHA.119.31588610.1161/CIRCRESAHA.119.315886 ↗
32. 10.1126/scisignal.aay568610.1126/scisignal.aay5686 ↗
33. 10.1002/glia.2288010.1002/glia.22880 ↗
34. 10.3389/fimmu.2019.0173810.3389/fimmu.2019.01738 ↗
35. 10.1016/j.jalz.2009.04.123310.1016/j.jalz.2009.04.1233 ↗
36. Yoshikawa T. · J. Nucl. Med. · 2003 · 44 · 505
37. 10.1007/s10072-018-3477-010.1007/s10072-018-3477-0 ↗
38. 10.3390/ijms2024617610.3390/ijms20246176 ↗
39. 10.1161/01.STR.0000143725.19053.6010.1161/01.STR.0000143725.19053.60 ↗
40. 10.18632/aging.10226010.18632/aging.102260 ↗
41. 10.1177/0271678X2094139310.1177/0271678X20941393 ↗
42. 10.1073/pnas.181069311510.1073/pnas.1810693115 ↗
43. 10.1016/j.jtcvs.2012.12.00610.1016/j.jtcvs.2012.12.006 ↗
44. 10.1515/revneuro-2017-001910.1515/revneuro-2017-0019 ↗
45. 10.7150/ijms.864710.7150/ijms.8647 ↗
46. 10.1039/c2mb25434d10.1039/c2mb25434d ↗
47. 10.1002/glia.2381910.1002/glia.23819 ↗
48. 10.1161/STROKEAHA.111.63649810.1161/STROKEAHA.111.636498 ↗
49. 10.1002/kjm2.1213610.1002/kjm2.12136 ↗
50. 10.1016/j.pneurobio.2021.10212510.1016/j.pneurobio.2021.102125 ↗
51. 10.1177/0271678X1769281510.1177/0271678X17692815 ↗
52. 10.1186/s40478-016-0350-310.1186/s40478-016-0350-3 ↗
53. 10.1186/s12974-020-01891-510.1186/s12974-020-01891-5 ↗
54. 10.1002/glia.2414710.1002/glia.24147 ↗
55. 10.7554/eLife.3064010.7554/eLife.30640 ↗
56. 10.1242/bio.02413310.1242/bio.024133 ↗
57. 10.1155/2014/76818110.1155/2014/768181 ↗
58. 10.1002/ijc.2601010.1002/ijc.26010 ↗
59. 10.1161/CIRCRESAHA.111.30041810.1161/CIRCRESAHA.111.300418 ↗
60. 10.1186/s12920-015-0156-310.1186/s12920-015-0156-3 ↗
61. 10.1016/j.brainres.2010.11.09610.1016/j.brainres.2010.11.096 ↗
62. 10.1046/j.1460-9568.2002.02200.x10.1046/j.1460-9568.2002.02200.x ↗
63. 10.1186/2040-7378-5-1210.1186/2040-7378-5-12 ↗
64. 10.1002/path.533910.1002/path.5339 ↗
65. 10.2174/092986732666619082715174110.2174/0929867326666190827151741 ↗
66. 10.1016/j.jddst.2017.11.01310.1016/j.jddst.2017.11.013 ↗
67. 10.3390/nano903037110.3390/nano9030371 ↗
68. 10.2217/nnm-2018-013910.2217/nnm-2018-0139 ↗
69. 10.1016/j.nano.2016.01.00210.1016/j.nano.2016.01.002 ↗
70. 10.3390/pharmaceutics1001003410.3390/pharmaceutics10010034 ↗
71. 10.1038/s41598-017-01819-910.1038/s41598-017-01819-9 ↗
72. 10.1016/j.colsurfb.2017.01.03110.1016/j.colsurfb.2017.01.031 ↗
73. 10.1016/j.ccr.2009.11.01910.1016/j.ccr.2009.11.019 ↗
74. Lueptow L. M. · J. Visualized Exp. · 2017
75. 10.1007/s10339-011-0430-z10.1007/s10339-011-0430-z ↗
76. 10.1007/s12035-017-0556-910.1007/s12035-017-0556-9 ↗
77. 10.1523/JNEUROSCI.3389-16.201710.1523/JNEUROSCI.3389-16.2017 ↗
78. 10.1038/s41467-018-06301-210.1038/s41467-018-06301-2 ↗
79. 10.1016/j.nano.2018.09.00510.1016/j.nano.2018.09.005 ↗